MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
1.253
-0.012 (-0.92%)
Nov 21, 2024, 3:09 PM EST - Market open
MIRA Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 21 | 16 | - | - | - |
| Enterprise Value | 17 | 10 | - | - | - |
| Last Close Price | 1.26 | 1.05 | - | - | - |
| PB Ratio | 5.76 | 3.55 | - | - | - |
| P/TBV Ratio | 5.92 | 3.55 | - | - | - |
| Debt / Equity Ratio | - | 0.00 | -0.82 | 0.13 | -1.32 |
| Quick Ratio | 5.98 | 8.27 | 0.26 | 2.57 | 0.04 |
| Current Ratio | 6.11 | 8.70 | 0.36 | 2.66 | 0.04 |
| Return on Equity (ROE) | -192.32% | -634.30% | -847.77% | -198.47% | - |
| Return on Assets (ROA) | -81.27% | -184.05% | -209.10% | -79.65% | - |
| Return on Capital (ROIC) | -91.51% | -249.33% | -359.67% | -104.42% | - |
| Earnings Yield | -54.08% | -77.21% | - | - | - |
| FCF Yield | -23.05% | -29.20% | - | - | - |
| Buyback Yield / Dilution | -9.59% | -5.69% | -38.60% | - | - |
| Total Shareholder Return | -9.59% | -5.69% | -38.60% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.